4 Einträge gefunden

1. Pembrolizumab outperforms tyrosine kinase inhibitors as adjuvant treatment in patients with high-risk renal cell carcinoma after nephrectomy

   1. Laukhtina, Ekaterina
   2. Quhal, Fahad
   3. Mori, Keiichiro
   4. Sari Motlagh, Reza
   5. Rajwa, Pawel
   6. Yanagisawa, Takafumi
   7. Mostafaei, Hadi

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Diagnostic Performance of Prostate-specific Membrane Antigen Positron Emission Tomography-targeted biopsy for Detection of Clinically Significant Prostate Cancer:A Systematic Review and Meta-analysis

   1. Kawada, Tatsushi
   2. Yanagisawa, Takafumi
   3. Rajwa, Pawel
   4. Sari Motlagh, Reza
   5. Mostafaei, Hadi
   6. Quhal, Fahad
   7. Laukhtina, Ekaterina

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Circulating Tumour DNA Is a Strong Predictor of Outcomes in Patients Treated with Systemic Therapy for Urothelial Carcinoma

   1. Laukhtina, Ekaterina
   2. Hassler, Melanie R
   3. Pradere, Benjamin
   4. Yanagisawa, Takafumi
   5. Quhal, Fahad
   6. Rajwa, Pawel
   7. Sari Motlagh, Reza

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomes

   1. Laukhtina, Ekaterina
   2. Sari Motlagh, Reza
   3. Mori, Keiichiro
   4. Katayama, Satoshi
   5. Rajwa, Pawel
   6. Yanagisawa, Takafumi
   7. Quhal, Fahad

   2021 - Forschungsinformationssystem des UKE - frei zugänglich